Major Depressive Disorder

Meenakshi Bewtra, MD, MPH, PhD, from the University of Pennsylvania, discussed medication failure as an important, but often forgotten, risk associated with 5-ASA in IBD, during a presentation at the 2019...

Ulcerative colitis (UC) is associated with a higher risk of colorectal cancer (CRC), but national data on admissions of CRC among patients with UC are scarce. Authors of a study presented at the 2019 AIBD...

Sunanda Kane, MD, discussed key points from the AGA IBD in Pregnancy Clinical Care Pathway report during a presentation at the 2019 AIBD Meeting.

Anti-tumor necrosis factor agents and/or thiopurines can prevent recurrence of Crohn disease in surgically treated patients, said Miguel Regueiro, MD, from the Cleveland Clinic, at the 2019 AIBD Meeting. ...

James Lewis, MD, explained how diet can influence the risk of developing Crohn disease and ulcerative colitis, as well as patient symptoms, during a presentation at the 2019 AIBD Meeting.

A retrospective observational cohort study presented at AIBD 2019 suggests that combination biologic therapy may be effective for certain patients with IBD.

In a new study presented at the 2019 AIBD Meeting, researchers assessed the prevalence of anastomotic ring inflammation (ARI) in patients with Crohn disease who undergo ileal resection and ileocolonic...

Brian Feagan, MD, discussed anti-integrin therapy for the treatment of patients with IBD during his presentation at the 2019 AIBD Meeting.